• Ticker:- BBH;false;MVBBH;
  • Ticker Group:- ETFEQ_IND;false;;
  • How to Purchase

Individual Investors

Subscribe to email updates

Subscribe now

Financial Professionals

Subscribe to email updates, or password protected financial professional-only content
email address/username
password

Biotech ETF BBH

  • Full Name: Market Vectors®
    Biotech ETF (BBH)

    Management Style: Replication

    Underlying Index: Market Vectors® US Listed Biotech 25 Index (MVBBHTR)

    Index Description: MVBBHTR is a rules-based index intended to track the overall performance of 25 of the largest U.S. listed, publicly traded biotech companies.

  •  
      

    • Fund Ticker

      BBH
    • Exchange

      NYSE Arca
    • Commencement

      12/20/2011
    • ETF Structure

      Physical
    • Administrator

      Van Eck Associates
    • Custodian

      Bank of New York Mellon
    • Index Ticker

      MVBBHTR
    • Index Rebalancing

      Quarterly
  •  
    as of 07/24/14

    • 30-Day SEC Yield1

      -0.11%
    • Total Net Assets

      $499.2M
    • Number of Holdings

      26
    • Options

      Available
    • Gross Expense Ratio2

      0.41%
    • Net Expense Ratio/TER2

      0.35%
    • Distribution Frequency

      Annual
    • Next Distribution Date

      12/19/2014
  • Portfolio Composition (%)
    as of 07/24/14

    • % of Net Assets
    • Stocks

      99.86
    • Bonds

      0.00
    • Other

      0.00
    • Cash

      0.14
  • Download All HoldingsAll Holdings (%)as of 07/24/14

    Total Holdings: 26
    Holding Name
    Ticker
    SharesMarket Value
    (US$)
    % of Net
    Assets
    Gilead Sciences Inc
    GILD US
    858,291
    77,709,66715.57
    Amgen Inc
    AMGN US
    466,654
    57,053,11811.43
    Celgene Corp
    CELG US
    585,809
    50,490,87810.12
    Biogen Idec Inc
    BIIB US
    148,166
    49,900,82710.00
    Vertex Pharmaceuticals Inc
    VRTX US
    292,772
    28,038,7745.62
    Alexion Pharmaceuticals Inc
    ALXN US
    143,907
    24,101,5444.83
    Regeneron Pharmaceuticals Inc
    REGN US
    69,910
    21,283,4004.26
    Illumina Inc
    ILMN US
    122,257
    21,003,7534.21
    Qiagen Nv
    QGEN US
    775,805
    19,302,0283.87
    Biomarin Pharmaceutical Inc
    BMRN US
    266,925
    16,405,2113.29
    Pharmacyclics Inc
    PCYC US
    155,722
    16,272,9493.26
    Incyte Corp Ltd
    INCY US
    336,101
    16,116,0433.23
    Medivation Inc
    MDVN US
    185,737
    14,015,7142.81
    Alkermes Plc
    ALKS US
    249,089
    11,385,8582.28
    Covance Inc
    CVD US
    119,159
    10,326,3192.07
    Cubist Pharmaceuticals Inc
    CBST US
    161,586
    10,123,3632.03
    United Therapeutics Corp
    UTHR US
    107,990
    9,970,7172.00
    Intercept Pharmaceuticals Inc
    ICPT US
    36,345
    8,267,9421.66
    Nps Pharmaceuticals Inc
    NPSP US
    228,148
    6,682,4551.34
    Isis Pharmaceuticals Inc
    ISIS US
    215,066
    6,585,3211.32
    Charles River Laboratories Internationa
    CRL US
    122,498
    6,583,0431.32
    Cepheid Inc
    CPHD US
    127,536
    5,171,5851.04
    Myriad Genetics Inc
    MYGN US
    126,338
    4,718,7240.95
    Seattle Genetics Inc
    SGEN US
    108,294
    3,756,7190.75
    Ariad Pharmaceuticals Inc
    ARIA US
    519,096
    3,213,2040.64
    Other/Cash
    678,2010.14
    These are not recommendations to buy or to sell any security. Securities and holdings may vary.